OR WAIT null SECS
November 11, 2022
The new Massachusetts facility will strengthen Cytiva’s cell culture services.
November 10, 2022
The results of the mid-term election may reduce Congress’ ability to pass FDA-related legislation during its lame duck session.
November 09, 2022
The UK MHRA has expanded the use of Cosentyx for use in pediatric arthritic conditions.
The latest guidance from FDA discusses recommendations on demonstrating sameness between the active ingredient in a proposed generic drug product and its reference listed drug.
November 08, 2022
The collaboration will see Shimadzu and UMG develop new clinical laboratory methods using LC-MS for TDM analysis.
MGI and Imperial College will jointly operate a CEC designed to provide European customers with first-hand experience with various automation and sequencing instruments.
Scorpion’s new facility is designed for the development and manufacturing of clinical and commercial-scale biologic drugs.
November 02, 2022
Industry and the government must work closely to ensure the UK remains a competitor in the clinical research field.
Gerresheimer and Nelson Labs will work together to conduct extractables and leachables testing on upcoming primary packaging solutions.
Under this deal, Merck, known as MSD outside of the United States and Canada, will select Veeva products for industry-specific software and data.